Ziprasidone EP Impurity A - CAS 87691-87-0
Catalog: |
BB038593 |
Product Name: |
Ziprasidone EP Impurity A |
CAS: |
87691-87-0 |
Synonyms: |
3-(1-Piperazinyl)-1,2-benzisothiazole; 3-(piperazin-1-yl)benzo[d]isothiazole; 3-Piperazin-1-yl-benzo[d]isothiazole; Ziprasidone Related Compound A |
IUPAC Name: | 3-piperazin-1-yl-1,2-benzothiazole |
Description: | An impurity of Ziprasidone, a combined serotonin (5HT2) and dopamine (D2) receptor antagonist. |
Molecular Weight: | 219.31 |
Molecular Formula: | C11H13N3S |
Canonical SMILES: | C1CN(CCN1)C2=NSC3=CC=CC=C32 |
InChI: | InChI=1S/C11H13N3S/c1-2-4-10-9(3-1)11(13-15-10)14-7-5-12-6-8-14/h1-4,12H,5-8H2 |
InChI Key: | KRDOFMHJLWKXIU-UHFFFAOYSA-N |
Boiling Point: | 320.2 °C at 760 mmHg |
Purity: | 98.0% |
Density: | 1.256 g/cm3 |
MDL: | MFCD04117970 |
LogP: | 2.09970 |
GHS Hazard Statement: | H301 (86.96%): Toxic if swallowed [Danger Acute toxicity, oral] |
Precautionary Statement: | P264, P270, P280, P301+P310, P302+P352, P305+P351+P338, P321, P330, P332+P313, P337+P313, P362, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-113087684-A | Application of bis (triphenylphosphine) carbonyl ruthenium dichloride monohydrate | 20210323 |
CN-113201020-A | Preparation method of bis (triphenylphosphine) carbonyl ruthenium dichloride monohydrate | 20210323 |
CN-113009042-A | Analysis and detection method of 3- (1-piperazinyl) -1, 2-benzisothiazole hydrochloride and related substances thereof | 20210316 |
WO-2021151493-A1 | Flame retardant chemical compositions | 20200130 |
JP-2021119130-A | A drug consisting of a fused lactam derivative | 20200129 |
PMID | Publication Date | Title | Journal |
22558126 | 20120101 | Synthesis and evaluation of a series of 2-substituted-5-thiopropylpiperazine (piperidine)-1,3,4-oxadiazoles derivatives as atypical antipsychotics | PloS one |
22570547 | 20120101 | Critical appraisal of lurasidone in the management of schizophrenia | Neuropsychiatric disease and treatment |
22115400 | 20110301 | Oral ziprasidone in the treatment of patients with bipolar disorders: a critical review | Expert review of clinical pharmacology |
14503666 | 20030101 | In vitro metabolism of perospirone in rat, monkey and human liver microsomes | European journal of drug metabolism and pharmacokinetics |
14503668 | 20030101 | Distribution of perospirone to melanin in pigmented rats | European journal of drug metabolism and pharmacokinetics |
Complexity: | 218 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 219.08301860 |
Formal Charge: | 0 |
Heavy Atom Count: | 15 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 219.08301860 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 56.4 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Piperazines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS